|Min SIP Amount||₹500|
|NAV||₹24.74 (22 Oct 2020)|
|Fund Started||02 Dec 2013|
|Fund Size||₹330 Cr|
|Natco Pharma Ltd.||Healthcare||Equity||5.0%|
|Max Financial Services Ltd.||Financial||Equity||4.2%|
|Voltas Ltd.||Cons Durable||Equity||3.7%|
|Syngene International Ltd.||Healthcare||Equity||3.4%|
|Alembic Pharmaceuticals Ltd.||Healthcare||Equity||3.3%|
|Whirlpool Of India Ltd.||Cons Durable||Equity||3.3%|
|PI Industries Ltd.||Chemicals||Equity||3.0%|
PGIM India Midcap Opportunities Fund Direct Growth is a Equity Mutual Fund Scheme launched by PGIM India Mutual Fund. This scheme was made available to investors on 02 Dec 2013. Kumaresh Ramakrishnan, Avinash Agarwal is the Current Fund Manager of PGIM India Midcap Opportunities Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹330 Cr and the Latest NAV as of 22 Oct 2020 is ₹24.74.
The PGIM India Midcap Opportunities Fund Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1%, if redeemed within one month.
The scheme seeks to achieve long-term capital appreciation by predominantly investing in equity & equity related instruments of mid cap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.